Fund shareholders of ORIC Pharmaceuticals Inc
ISIN US68622P1093 · United States · LEI 54930033FJRNEYBW0L25
- Fund shareholders
- 188
- Of which ETFs
- 39 149 other funds
- Value held
- 290.6M $
- Share of capital
- 22.8 % of 103.7M shares on Jul 27, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,738,573 | 34.7M $ | 0.00 % | 2.64 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2,171,512 | 27.5M $ | 0.37 % | 2.09 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,740,383 | 22.1M $ | 0.20 % | 1.68 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,622,032 | 20.6M $ | 0.03 % | 1.56 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 985,136 | 12.5M $ | 0.10 % | 0.95 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 951,433 | 12.1M $ | 0.76 % | 0.92 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 950,201 | 12M $ | 0.15 % | 0.92 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 859,828 | 10.9M $ | 0.01 % | 0.83 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 718,374 | 9.7M $ | 0.01 % | 0.69 % | as of Feb 28, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 659,005 | 6.5M $ | 0.63 % | 0.64 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 654,689 | 6.5M $ | 0.02 % | 0.63 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 424,422 | 5.4M $ | 0.07 % | 0.41 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 406,190 | 5.5M $ | 0.01 % | 0.39 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 402,972 | 5.1M $ | 0.04 % | 0.39 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 388,005 | 3.8M $ | 0.02 % | 0.37 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 371,776 | 5M $ | 0.02 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Meridian Contrarian Fund Meridian Fund Inc | 370,000 | 4.7M $ | 0.80 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 358,298 | 3.5M $ | 0.25 % | 0.35 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 327,996 | 4.4M $ | 0.03 % | 0.32 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 327,184 | 3.2M $ | 0.02 % | 0.32 % | as of Apr 30, 2026 ↗ |
| Royce Small-Cap Fund ROYCE FUND | 324,780 | 4.1M $ | 0.23 % | 0.31 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 280,851 | 2.8M $ | 0.04 % | 0.27 % | as of Apr 30, 2026 ↗ |
| Victory RS Small Cap Growth Fund Victory Portfolios | 273,610 | 3.5M $ | 1.04 % | 0.26 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 233,347 | 3.1M $ | 0.01 % | 0.23 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 166,686 | 2.1M $ | 0.17 % | 0.16 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 156,262 | 2M $ | 0.14 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Royce Micro-Cap Fund ROYCE FUND | 154,645 | 2M $ | 0.61 % | 0.15 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 152,677 | 1.9M $ | 0.02 % | 0.15 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 151,300 | 1.9M $ | 0.12 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Meridian Small Cap Growth Fund Meridian Fund Inc | 150,199 | 1.9M $ | 0.81 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 144,716 | 1.9M $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 143,871 | 1.4M $ | 0.02 % | 0.14 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 142,329 | 1.4M $ | 0.00 % | 0.14 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 131,478 | 1.8M $ | 0.01 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 124,292 | 1.2M $ | 0.24 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 124,174 | 1.7M $ | 0.07 % | 0.12 % | as of Feb 28, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 115,957 | 1.5M $ | 0.13 % | 0.11 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 112,825 | 1.4M $ | 0.00 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 111,853 | 1.5M $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 110,459 | 1.4M $ | 0.21 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 104,008 | 1.3M $ | 0.03 % | 0.10 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 102,259 | 1.3M $ | 0.12 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 97,392 | 962.2K $ | 0.00 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Victory RS Science & Technology Fund Victory Portfolios | 92,540 | 1.2M $ | 0.62 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 85,713 | 1.1M $ | 0.03 % | 0.08 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 85,636 | 1.1M $ | 0.62 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Value Insights Fund Goldman Sachs Trust | 80,049 | 790.9K $ | 0.07 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 79,998 | 790.4K $ | 0.02 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 71,032 | 701.8K $ | 0.03 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 69,361 | 685.3K $ | 0.02 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 68,190 | 864K $ | 0.14 % | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 67,269 | 852.3K $ | 0.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 62,694 | 619.4K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 58,798 | 745K $ | 0.04 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 58,568 | 787.7K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 53,408 | 718.3K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Royce Capital Fund - Micro-Cap Portfolio ROYCE CAPITAL FUND | 49,504 | 627.2K $ | 0.61 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 49,356 | 625.3K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 46,330 | 623.1K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 45,633 | 450.9K $ | 0.06 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 41,888 | 413.9K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 41,409 | 524.7K $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 41,012 | 519.6K $ | 0.23 % | 0.04 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 40,800 | 516.9K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 40,741 | 402.5K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 38,766 | 491.2K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 38,468 | 380.1K $ | 0.21 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 35,407 | 476.2K $ | 0.30 % | 0.03 % | as of Feb 28, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 34,790 | 440.8K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 34,530 | 464.4K $ | 0.04 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 32,328 | 409.6K $ | 0.20 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 31,335 | 397K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 31,152 | 394.7K $ | 0.13 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Empower Small Cap Growth Fund EMPOWER FUNDS, INC. | 30,854 | 390.9K $ | 0.17 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 30,514 | 301.5K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 30,496 | 386.4K $ | 0.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 29,424 | 290.7K $ | 0.78 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 28,629 | 282.9K $ | 0.02 % | 0.03 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 28,225 | 357.6K $ | 0.23 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 27,073 | 267.5K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 26,880 | 361.5K $ | 0.03 % | 0.03 % | as of Feb 28, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 26,854 | 265.3K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Small Cap Value Fund VALIC Co I | 25,146 | 338.2K $ | 0.13 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 24,470 | 310K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 24,083 | 323.9K $ | 0.02 % | 0.02 % | as of Feb 28, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 23,780 | 301.3K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 23,000 | 291.4K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 21,017 | 266.3K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 20,325 | 257.5K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 20,039 | 198K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 19,330 | 244.9K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 18,074 | 229K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 17,948 | 227.4K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 17,404 | 220.5K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 17,167 | 230.9K $ | 0.02 % | 0.02 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 16,566 | 209.9K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 15,666 | 154.8K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust | 15,330 | 194.2K $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 14,890 | 188.7K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 14,270 | 180.8K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Victory RS Small Cap Growth Fund Victory Portfolios | 1.04 % | as of Mar 31, 2026 ↗ |
| Meridian Small Cap Growth Fund Meridian Fund Inc | 0.81 % | as of Mar 31, 2026 ↗ |
| Meridian Contrarian Fund Meridian Fund Inc | 0.80 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.78 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.76 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.63 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.62 % | as of Mar 31, 2026 ↗ |
| Victory RS Science & Technology Fund Victory Portfolios | 0.62 % | as of Mar 31, 2026 ↗ |
| Royce Capital Fund - Micro-Cap Portfolio ROYCE CAPITAL FUND | 0.61 % | as of Mar 31, 2026 ↗ |
| Royce Micro-Cap Fund ROYCE FUND | 0.61 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 188 | +10 | 23,628,150 | +7.4 % |
| 2026Q1 | 178 | +5 | 22,008,712 | +16.7 % |
| 2025Q4 | 173 | +15 | 18,855,146 | +21.8 % |
| 2025Q3 | 158 | -11 | 15,482,340 | +8.5 % |
| 2025Q2 | 169 | +11 | 14,269,242 | +5.6 % |
| 2025Q1 | 158 | -2 | 13,509,134 | +4.8 % |
| 2024Q4 | 160 | +11 | 12,891,388 | -8.2 % |
| 2024Q3 | 149 | +6 | 14,041,162 | +5.5 % |
| 2024Q2 | 143 | +17 | 13,310,375 | +13.6 % |
| 2024Q1 | 126 | +7 | 11,715,823 | -4.7 % |
| 2023Q4 | 119 | 12,294,844 |
Institutional managers
175 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Nextech Invest, Ltd. | 7,162,637 | 90.8M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 6,728,116 | 85.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,984,552 | 75.8M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 5,824,533 | 73.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5,387,783 | 68.3K $ | as of Mar 31, 2026 |
| Pfizer Inc | 4,780,401 | 57.7M $ | as of Mar 31, 2026 |
| SR One Capital Management, LP | 4,514,929 | 58.5M $ | as of Mar 31, 2026 |
| ALKEON CAPITAL MANAGEMENT LLC | 4,504,096 | 57.1M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 4,319,765 | 54.7M $ | as of Mar 31, 2026 |
| NEA Management Company, LLC | 4,118,621 | 52.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,702,196 | 46.9M $ | as of Mar 31, 2026 |
| Column Group LLC | 3,540,777 | 44.9M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 2,998,192 | 38M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 2,693,929 | 34.1M $ | as of Mar 31, 2026 |
| AIHC Capital Management Ltd | 2,459,551 | 31.2M $ | as of Mar 31, 2026 |
| FMR LLC | 2,434,080 | 30.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,422,741 | 30.7M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 2,017,284 | 25.6M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 1,848,786 | 23.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,838,801 | 23.3M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,803,945 | 22.9M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 1,701,217 | 21.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,682,523 | 21.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,475,712 | 18.7M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,471,290 | 18.6M $ | as of Mar 31, 2026 |
Declared shareholders of ORIC Pharmaceuticals Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP and 9 others | 7.80 % | 8,264,607 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Associates, Inc. | 5.40 % | 5,387,783 | as of Mar 31, 2026 · SCHEDULE 13G |
| Venrock Healthcare Capital Partners III, L.P. and 6 others | 4.20 % | 4,319,765 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ORIC Pharmaceuticals Inc". https://titelia.com/en/stocks/oric-pharmaceuticals-inc-US68622P1093